US Stock MarketDetailed Quotes

Citius Oncology (CTOR)

Watchlist
  • 0.9633
  • -0.0210-2.13%
Close May 15 16:00 ET
  • 0.8650
  • -0.0983-10.20%
Post 20:01 ET
85.04MMarket Cap-3.11P/E (TTM)

Citius Oncology (CTOR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Total revenue
3.94M
0
0
0
0
0
0
0
0
0
Operating revenue
--3.94M
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
789.21K
0
Gross profit
3.15M
0
Operating expense
22.50%7.83M
14.34%23.52M
-29.35%4.71M
6.83%4.94M
59.25%7.47M
39.52%6.39M
69.72%20.57M
6.67M
4.63M
4.69M
Selling and administrative expenses
32.84%6.82M
9.31%17.1M
-32.34%3.64M
14.56%4.01M
29.60%4.33M
49.36%5.13M
98.56%15.65M
--5.37M
--3.5M
--3.34M
-General and administrative expense
32.84%6.82M
9.31%17.1M
-32.34%3.64M
14.56%4.01M
29.60%4.33M
49.36%5.13M
98.56%15.65M
--5.37M
--3.5M
--3.34M
Research and development costs
-19.47%1.02M
30.32%6.42M
-16.97%1.08M
-17.07%938.28K
132.73%3.14M
10.10%1.26M
16.14%4.93M
--1.3M
--1.13M
--1.35M
Operating profit
26.84%-4.68M
-14.34%-23.52M
29.35%-4.71M
-6.83%-4.94M
-59.25%-7.47M
-39.52%-6.39M
-69.72%-20.57M
-6.67M
-4.63M
-4.69M
Net non-operating interest income expense
-17.55K
-181.66K
-20.9K
-160.76K
0
0
Non-operating interest income
--28.29K
--36.37K
----
----
----
--0
--0
----
----
----
Non-operating interest expense
--45.84K
--218.03K
--57.28K
--160.76K
----
--0
--0
----
----
----
Other net income (expense)
-573.44K
Special income (charges)
---573.44K
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--573.44K
----
----
----
----
----
----
----
----
----
Income before tax
17.59%-5.27M
-15.22%-23.7M
29.04%-4.73M
-10.30%-5.11M
-59.25%-7.47M
-39.52%-6.39M
-69.72%-20.57M
-6.67M
-4.63M
-4.69M
Income tax
0.00%264.24K
83.50%1.06M
83.50%264.24K
83.50%264.24K
83.50%264.24K
83.50%264.24K
0.00%576K
144K
144K
144K
Net income
16.90%-5.53M
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
-6.81M
-4.77M
-4.84M
Net income continuous Operations
16.90%-5.53M
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
---6.81M
---4.77M
---4.84M
Minority interest income
Net income attributable to the parent company
16.90%-5.53M
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
-6.81M
-4.77M
-4.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.90%-5.53M
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
-6.81M
-4.77M
-4.84M
Basic earnings per share
33.33%-0.06
-9.68%-0.34
36.99%-0.06
-19.41%-0.08
-62.06%-0.11
-35.63%-0.09
-73.93%-0.31
-0.0952
-0.067
-0.0679
Diluted earnings per share
33.33%-0.06
-9.68%-0.34
36.99%-0.06
-19.41%-0.08
-62.06%-0.11
-35.63%-0.09
-73.93%-0.31
-0.0952
-0.067
-0.0679
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Total revenue 3.94M000000000
Operating revenue --3.94M--0--0--0--0--0--0--0--0--0
Cost of revenue 789.21K0
Gross profit 3.15M0
Operating expense 22.50%7.83M14.34%23.52M-29.35%4.71M6.83%4.94M59.25%7.47M39.52%6.39M69.72%20.57M6.67M4.63M4.69M
Selling and administrative expenses 32.84%6.82M9.31%17.1M-32.34%3.64M14.56%4.01M29.60%4.33M49.36%5.13M98.56%15.65M--5.37M--3.5M--3.34M
-General and administrative expense 32.84%6.82M9.31%17.1M-32.34%3.64M14.56%4.01M29.60%4.33M49.36%5.13M98.56%15.65M--5.37M--3.5M--3.34M
Research and development costs -19.47%1.02M30.32%6.42M-16.97%1.08M-17.07%938.28K132.73%3.14M10.10%1.26M16.14%4.93M--1.3M--1.13M--1.35M
Operating profit 26.84%-4.68M-14.34%-23.52M29.35%-4.71M-6.83%-4.94M-59.25%-7.47M-39.52%-6.39M-69.72%-20.57M-6.67M-4.63M-4.69M
Net non-operating interest income expense -17.55K-181.66K-20.9K-160.76K00
Non-operating interest income --28.29K--36.37K--------------0--0------------
Non-operating interest expense --45.84K--218.03K--57.28K--160.76K------0--0------------
Other net income (expense) -573.44K
Special income (charges) ---573.44K------------------0----------------
-Less:Other special charges --573.44K------------------------------------
Income before tax 17.59%-5.27M-15.22%-23.7M29.04%-4.73M-10.30%-5.11M-59.25%-7.47M-39.52%-6.39M-69.72%-20.57M-6.67M-4.63M-4.69M
Income tax 0.00%264.24K83.50%1.06M83.50%264.24K83.50%264.24K83.50%264.24K83.50%264.24K0.00%576K144K144K144K
Net income 16.90%-5.53M-17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M-6.81M-4.77M-4.84M
Net income continuous Operations 16.90%-5.53M-17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M---6.81M---4.77M---4.84M
Minority interest income
Net income attributable to the parent company 16.90%-5.53M-17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M-6.81M-4.77M-4.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.90%-5.53M-17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M-6.81M-4.77M-4.84M
Basic earnings per share 33.33%-0.06-9.68%-0.3436.99%-0.06-19.41%-0.08-62.06%-0.11-35.63%-0.09-73.93%-0.31-0.0952-0.067-0.0679
Diluted earnings per share 33.33%-0.06-9.68%-0.3436.99%-0.06-19.41%-0.08-62.06%-0.11-35.63%-0.09-73.93%-0.31-0.0952-0.067-0.0679
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More